☰
✕

Leptospirosis market

Leptospirosis Market, by Drug (Amoxicillin, Azithromycin, Cefixime, Doxycycline, Others (Ceftriaxone,Penicillin among others)), by Diagnosis (Complete Blood Count (CBC), Creatine Kinase, Liver Enzymes, Urinalysis, Others (Lumbar puncture, Microscopic agglutination test among others)), by Route of Administration (Oral, Parenteral, Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Request Free Sample
  • May 2023
  • CMI5761
  • 339 Pages
  • Excel & Pdf
  • Pharmaceutical

The global leptospirosis market is estimated to be valued at US$ 496.8 million in 2023 and is expected to exhibit a CAGR of 5.8% during the forecast period (2023-2030).

Analysts’ Views on Global Leptospirosis Market:

Global leptospirosis market's growth is expected to drive the growth of the market owing to the increasing disease awareness by government authorities for the treatment of leptospirosis. For instance, on November 28, 2022, the government of the Republic of Trinidad and Tobago, Port of Spain, announced a statement regarding leptospirosis awareness for the public to protect against leptospirosis, which shows symptoms like high fever, headache, muscle aches, diarrhoea, jaundice, and other symptoms. As a result, government officials advised the public to get tested for leptospirosis before beginning early treatment.This is expected to increase the demand for medicines in the region for the treatment of leptospirosis in the near future.

Figure 1. Global Leptospirosis Market Share (%), By Drug, 2023

Global Leptospirosis Market – Driver

Ongoing research and development by key market players

Ongoing research and development for vaccine development against leptospirosis by key market players are expected to drive the global leptospirosis market over the forecast period. For instance, on January 26, 2021, eLife, a non-profit organization created by funders and led by researchers, issued a statement stating that the scientists had designed a single-dose universal vaccine that could protect against the many forms of leptospirosis bacteria. According to a study published in eLife, a peer-reviewed journal, an effective vaccine would help prevent the life-threatening conditions caused by leptospirosis, such as Weil’s disease and lung hemorrhage, which are fatal in 10% and 50% of cases, respectively. In the preclinical study, the data has shown that a universal leptospirosis vaccine candidate can prevent both death and kidney colonization in animal models.

Figure 2. Global Leptospirosis Market Value (US$ Million), by Region, 2023

Global Leptospirosis Market- Regional Analysis

Among regions, Africa is estimated to hold a dominant position in the global leptospirosis market over the forecast period owing to the increasing prevalence of leptospirosis in the region. For instance, on July 14, 2022, according to the World Health Organization (WHO), the Ministry of Health (MoH) of the United Republic of Tanzania, Africa, notified WHO of 13 cases of leptospirosis. The first two cases were presented to a health center located in Ruangwa District, Lindi Region, on July 5 and 7,2022,  with symptoms of fever, bleeding from the nose, headache, and general body weakness. Thus, the demand for the drug required for leptospirosis treatment is going to rise in the near future, which is expected to drive the growth of the market over the forecast period.

Global Leptospirosis Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global leptospirosis market. For instance, on January 10, 2022, an article published in the Korean Society of Epidemiology, a scientific journal, stated about the outbreak of leptospirosis in Sri Lanka during the COVID-19 pandemic that the coronavirus disease 2019 (COVID-19) pandemic disrupted the global health systems and affected the transmission dynamics as well as the surveillance of other infectious diseases. This study described the probable effect of the COVID-19 pandemic on the surveillance and control of leptospirosis in Sri Lanka. With 8,579 reported cases and more than 800 estimated deaths, the Sri Lankan public health surveillance system documented the largest outbreak of leptospirosis in Sri Lankan history in 2020. This was the worst infectious disease outbreak Sri Lanka experienced in 2020, but it was neglected, primarily due to the COVID-19 pandemic.

Leptospirosis Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 496.8 Mn
Historical Data for: 2017 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 5.8% 2030 Value Projection: US$ 739.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Drug: Amoxicillin, Azithromycin, Cefixime, Doxycycline, Others (Ceftriaxone, Penicillin Among Others)
  • By Diagnosis: Complete Blood Count (CBC), Creatine Kinase, Liver Enzymes, Urinalysis, Others (Lumbar puncture, Microscopic agglutination test among others)
  • By Route of Administration: Oral, Parenteral, Intravenous
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 
Companies covered:

USAntibiotics, Dr. Reddy’s Laboratories Ltd., Century Pharmaceuticals Ltd., Mayne Pharma Group Limited, Sun Pharmaceutical Industries, Inc., Ralington Pharma, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, ISKON REMEDIES & GMT, Haustus Biotech Pvt. Ltd., and Aden Healthcare
Growth Drivers:
  • Ongoing research and development by key market players
Restraints & Challenges:
  • Lack of standardization of diagnostic testing and treatment alternatives for the prevention and control of Leptospirosis

Global Leptospirosis Market Segmentation:

The global leptospirosis market report is segmented into Drug, Diagnosis, Route of Administration, and Distribution Channel

Based on Drug, the market is segmented into amoxicillin, azithromycin, cefixime, doxycycline, and others (ceftriaxone, penicillin among others). Out of which, the amoxicillin segment is expected to dominant position in global leptospirosis market during the forecast period and this is attributed due to the increase in the use of Amoxicillin for the treatment of Leptospirosis based on guidelines published by government authorities.

Based on Diagnosis, the market is segmented into complete blood count (CBC), creatine kinase, liver enzymes, urinalysis, and others which include lumbar puncture, microscopic agglutination test, and others. Out of which, completed blood count (CBC) segment is expected to dominate the market over the forecast period.

Based on Route of Administration, the market is segmented into oral, parenteral, and intravenous. Out of which, oral segment is expected to dominate the market over the forecast period and this is attributed to the increased use of antibiotics for the treatment of leptospirosis.

Based on Distribution Channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Out of which, hospital pharmacies segment is expected to dominate the market over the forecast period and this is attributed to the increase in the number of hospital pharmacies.

Based on Region, Africa is expected to hold a dominant position in the market among all the regions due to increasing awareness programs in the regions for leptospirosis for early detection and treatment

Among all segmentation, drug segment has the highest potential due to the increasing use of off-label antibiotics for the treatment of leptospirosis as there is no approved product by regulatory authorities available in the market.

Global Leptospirosis Market Cross Sectional Analysis:

In the distribution channel segment, hospital pharmacies held a dominant segment in North America region due to the increasing number of hospital pharmacies. For instance, in January 2022, according to data provided by the National Association of Pharmacy Regulatory Authorities, there were 11,814 pharmacies in Canada in January 2022.

Global Leptospirosis Market: Key Developments

Increasing expansion of diagnostics laboratory for leptospirosis by government authorities over the forecast period. For instance, On November 11, 2022, The Minister for Health and Family Welfare of Tamil Nadu, India, announced the inauguration of the Regional Leptospirosis Diagnostics Laboratory (RLDL) to strengthen diagnostic facilities for leptospirosis at the State Public Health Laboratory of the Directorate of Public Health (DPH) and Preventive Medicine in Chennai, India.

Global Leptospirosis Market: Key Trends

Increasing adoption of highly efficient diagnostic methods for the detection of leptospirosis

Increasing adoption of highly efficient diagnostic methods for the detection of leptospirosis is expected to drive the global leptospirosis market over the forecast period. For instance, on September 30, 2022, an article published by Research Square, a peer-reviewed journal, stated that "Early diagnosis by metagenomics next-generation sequencing (mNGS) improves the prognosis for severe leptospirosis patients," which resulted in "mNGS being highly efficient in diagnosing leptospirosis and could reduce the mortality rate if used at an early stage." This was expected to raise the demand for treatment after early detection, which is expected to drive the growth of the market over the forecast period.

Global Leptospirosis Market: Restraint

Lack of standardization of diagnostic testing and treatment alternatives for the prevention and control of Leptospirosis

Global leptospirosis market growth can be hindered by lack of standardization of diagnostic testing and approved treatment alternatives for the prevention and control of leptospirosis. For instance, on September 22, 2021, According to the data published by the Department Of Health And Mental Hygiene Human cases of leptospirosis, New York City. the staeted that Fourteen people diagnosed with leptospirosis have been reported to date in 2021, more than the total number reported to the New York City Health Department in any prior year. The majority of patients were hospitalized with acute renal and hepatic failure, two of whom also had severe pulmonary involvement. Leptospirosis is treated with antibiotics, such as doxycycline or penicillin, which should be given early in the course of the disease.

Thus it is required to focus on research and development activities for the development of drugs indicated for the treatment of Leptospirosis

 

 

Global Leptospirosis Market - Key Players

Major players operating in the global leptospirosis market include USAntibiotics, Dr. Reddy’s Laboratories Ltd., Century Pharmaceuticals Ltd., Mayne Pharma Group Limited, Sun Pharmaceutical Industries, Inc., Ralington Pharma, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, ISKON REMEDIES & GMT, Haustus Biotech Pvt. Ltd., and Aden Healthcare

*Definition: Leptospirosis is a bacterial disease that affects humans and animals. It is caused by bacteria of the genus Leptospira. In humans, it can cause a wide range of symptoms, some of which may be mistaken for other diseases. Some infected persons, however, may have no symptoms at all.

Global Leptospirosis Market– Insights

The bacterial illness leptospirosis can affect both people and animals. Leptospira bacteria are to blame for their development. It can have a wide range of symptoms in people, some of which may be confused with those of other illnesses. However, some infected people might not even exhibit any symptoms. Leptospirosis is contracted by water or by diseased animals' urine, which contains germs that can persist for weeks or months in soil. The bacterium is carried by many different species of wild and domesticated animals.

 

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug
      • Market Snapshot, By Diagnosis
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Guidelines
    • Product launches
    • Key Development
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Leptospirosis Market- Impact of Coronavirus (Covid-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the market
  5. Global Leptospirosis Market, By Drug, 2018 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Amoxicillin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Azithromycin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Cefixime
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Doxycycline
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Others (Ceftriaxone, Penicillin among others)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
  6. Global Leptospirosis Market, By Diagnosis, 2018 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Complete Blood Count (CBC)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Creatine Kinase
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Liver Enzymes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Urinalysis
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Others (Lumbar puncture, Microscopic agglutination test among others)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
  7. Global Leptospirosis Market, By Route of Administration, 2018 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Oral
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Parenteral
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Intravenous
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
  8. Global Leptospirosis Market, By Distribution Channel, 2018 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
  9. Global Leptospirosis Market, By Region, 2018 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2030
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2018 – 2030, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • USAntibiotics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Reddy’s Laboratories Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Century Pharmaceuticals Ltd.
      • Company Highlight
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mayne Pharma Group Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sun Pharmaceutical Industries, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ralington Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sandoz International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ISKON REMEDIES & GMT
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Haustus Biotech Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aden Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  11. Section
    • Research Methodology
    • About Us

*Browse 58 market data tables and 53 figures on "Global Leptospirosis Market” - forecast to 2030

Detailed Segmentation:

  • Global Leptospirosis Market, By Drug:
    • Amoxicillin
    • Azithromycin
    • Cefixime
    • Doxycycline
    • Others (Ceftriaxone,Penicillin among others)
  • Global Leptospirosis Market, By Diagnosis:
    • Complete Blood Count (CBC)
    • Creatine Kinase
    • Liver Enzymes
    • Urinalysis
    • Others (Lumbar puncture, Microscopic agglutination test among others)
  • Global Leptospirosis Market, By Route of Administration:
    • Oral
    • Parenteral
    • Intravenous
  • Global Leptospirosis Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Leptospirosis Market, By Region:
    • North America
      • By Drug
        • Amoxicillin
        • Azithromycin
        • Cefixime
        • Doxycycline
        • Others (Ceftriaxone, Penicillin among others)
      • By Diagnosis
        • Complete Blood Count (CBC)
        • Creatine Kinase
        • Liver Enzymes
        • Urinalysis
        • Others (Lumbar puncture, Microscopic agglutination test among others)
      • By Route of Administration
        • Oral
        • Parenteral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Drug
        • Amoxicillin
        • Azithromycin
        • Cefixime
        • Doxycycline
        • Others (Ceftriaxone, Penicillin among others)
      • By Diagnosis
        • Complete Blood Count (CBC)
        • Creatine Kinase
        • Liver Enzymes
        • Urinalysis
        • Others (Lumbar puncture, Microscopic agglutination test among others)
      • By Route of Administration
        • Oral
        • Parenteral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug
        • Amoxicillin
        • Azithromycin
        • Cefixime
        • Doxycycline
        • Others (Ceftriaxone, Penicillin among others)
      • By Diagnosis
        • Complete Blood Count (CBC)
        • Creatine Kinase
        • Liver Enzymes
        • Urinalysis
        • Others (Lumbar puncture, Microscopic agglutination test among others)
      • By Route of Administration
        • Oral
        • Parenteral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug
        • Amoxicillin
        • Azithromycin
        • Cefixime
        • Doxycycline
        • Others (Ceftriaxone, Penicillin among others)
      • By Diagnosis
        • Complete Blood Count (CBC)
        • Creatine Kinase
        • Liver Enzymes
        • Urinalysis
        • Others (Lumbar puncture, Microscopic agglutination test among others)
      • By Route of Administration
        • Oral
        • Parenteral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug
        • Amoxicillin
        • Azithromycin
        • Cefixime
        • Doxycycline
        • Others (Ceftriaxone, Penicillin among others)
      • By Diagnosis
        • Complete Blood Count (CBC)
        • Creatine Kinase
        • Liver Enzymes
        • Urinalysis
        • Others (Lumbar puncture, Microscopic agglutination test among others)
      • By Route of Administration
        • Oral
        • Parenteral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug
        • Amoxicillin
        • Azithromycin
        • Cefixime
        • Doxycycline
        • Others (Ceftriaxone, Penicillin among others)
      • By Diagnosis
        • Complete Blood Count (CBC)
        • Creatine Kinase
        • Liver Enzymes
        • Urinalysis
        • Others (Lumbar puncture, Microscopic agglutination test among others)
      • By Route of Administration
        • Oral
        • Parenteral
        • Intravenous
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Regions
        • South Africa
        • Central Africa
        • North Africa
- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global leptospirosis market during the forecast period (2023-2030)?

The global leptospirosis market is estimated to be valued at US$ 496.8 million in 2023 and is expected to exhibit a CAGR of 5.8% between 2023 and 2030.

What are the major factors driving the market growth?

Ongoing research and development by key market players for the leptospirosis treatment is expected to drive the market growth

Which is the leading drug segment in the market?

Amoxicillin is the leading type segment in the market.

What are the key factors hampering the growth of the market?

Lack of standardization of diagnostic testing and treatment alternatives for the prevention and control of Leptospirosis is expected to hinder the global leptospirosis market over the forecast period

Which are the major players operating in the market?

Major players operating in the market include USAntibiotics, Dr. Reddy’s Laboratories Ltd., Century Pharmaceuticals Ltd., Mayne Pharma Group Limited, Sun Pharmaceutical Industries, Inc., Ralington Pharma, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, ISKON REMEDIES & GMT, Haustus Biotech Pvt. Ltd., and Aden Healthcare
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Buy Now with Special Discount
Customize Now